CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
A Phase 2 Multi-center Open-label Trial of nab-Sirolimus in Combination with Letrozole in Advanced or Recurrent Endometrioid Endometrial Cancer...
Phase 2
Charlotte, North Carolina, United States and 8 other locations
participants with recurrent or primary advanced (Stage III or IV) endometrial cancer....
Phase 3
Charlotte, North Carolina, United States and 168 other locations
advanced solid tumors. Subjects with all histologic types of solid tumors are eligible for the escalation and dose-finding portion ...
Phase 1
Huntersville, North Carolina, United States of America and 10 other locations
A phase 1a/1b, multicenter, open-label, dose escalation/expansion, multiple-dose study to evaluate the safety and activity of DR-0202 in patients wit...
Phase 1
Huntersville, North Carolina, United States and 9 other locations
study is studying a new compound, AZD8205, as a possible treatment for advanced or metastatic solid tumours alone or in combination with anti-cancer...
Phase 1, Phase 2
Charlotte, North Carolina, United States and 65 other locations
The purpose of this study is to evaluate the efficacy and safety of selinexor as a maintenance treatment in patients with p53 wt endometrial...
Phase 3
Charlotte, North Carolina, United States and 206 other locations
in participants with select loco-regionally recurrent solid tumors or metastatic solid tumors where curative or standard treatment ...
Phase 1
Charlotte, North Carolina, United States and 23 other locations
This is a study to evaluate the safety and potential anti-tumor activity of an investigational agent called ARV-806 in Adults with Advanced ...
Phase 1, Phase 2
Huntersville, North Carolina, United States and 3 other locations
Phase 1/2, open-label study of ETX-636 in participants with advanced solid tumors...
Phase 1, Phase 2
Huntersville, North Carolina, United States of America and 2 other locations
The purpose of this study is to find out whether the study drug, LY3537982, is safe and effective in cancer patients who have a specific gen...
Phase 1, Phase 2
Charlotte, North Carolina, United States and 49 other locations
Clinical trials
Research sites
Resources
Legal